一项全国多中心院前ECPR阶梯楔形研究:ON-SCENE研究设计与原理
ON-SCENE研究采用非随机阶梯楔形设计,在见证的18-50岁、初始为可电击心律或高度怀疑肺栓塞的无脉电活动、持续20-45分钟的OHCA患者中,由具备院前ECPR能力的HEMS团队在事发现场启动ECPR,并与无院前ECPR能力的HEMS常规救治比较。主要终点为出院生存率,次要终点为6个月和12个月脑功能分类量表评分1或2的良好神经功能结局。研究假设HEMS启动ECPR可缩短低血流时间并改善预后。试验注册于ClinicalTrials.gov NCT04620070,注册日期2020年11月3日。
要点
- ON-SCENE研究纳入见证的18-50岁OHCA,初始为可电击心律或高度怀疑肺栓塞的无脉电活动,持续>20分钟且<45分钟。
- 干预为具备院前ECPR能力的HEMS团队在事发现场启动ECPR,对照为无院前ECPR能力的HEMS常规救治。
- 主要终点为出院生存率,次要终点为6个月和12个月脑功能分类量表评分1或2的良好神经功能结局。
- 研究采用非随机阶梯楔形设计,假设院前ECPR可缩短低血流时间并改善难治性OHCA预后。
适用人群与场景
- 见证的院外心脏骤停(OHCA)患者,年龄18-50岁。
- 初始表现为可电击心律,或高度怀疑肺栓塞的无脉电活动(PEA)。
- 心脏骤停持续时间超过20分钟但少于45分钟。
诊断标准与关键阈值
- 难治性OHCA:见证的骤停,年龄18-50岁,初始可电击心律或高度怀疑肺栓塞的PEA,持续>20分钟且<45分钟。
处置流程与药物剂量
- 由具备院前ECPR能力的HEMS团队在事发现场启动ECPR(静脉-动脉体外膜氧合)。
- 对照措施为无院前ECPR能力的HEMS团队常规救治。
研究设计与关键结果
- 研究类型:非随机阶梯楔形设计,全国多中心研究。
- 人群:见证的OHCA,年龄18-50岁,初始可电击心律或高度怀疑肺栓塞的PEA,骤停持续>20分钟且<45分钟。
- 干预与对照:具备院前ECPR能力的HEMS在事发现场启动ECPR vs 无院前ECPR能力的HEMS常规救治。
- 主要终点:出院生存率。
- 次要终点:6个月和12个月脑功能分类量表评分1或2的良好神经功能结局。
证据类型、等级与局限
- 证据类型:研究方案(非随机阶梯楔形设计)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- ON-SCENE研究方案,注册于ClinicalTrials.gov NCT04620070,注册日期2020年11月3日。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The likelihood of return of spontaneous circulation with conventional advanced life support is known to have an exponential decline and therefore neurological outcome after 20 min in patients with a cardiac arrest is poor. Initiation of venoarterial ExtraCorporeal Membrane Oxygenation (ECMO) during resuscitation might improve outcomes if used in time and in a selected patient category. However, previous studies have failed to significantly reduce the time from cardiac arrest to ECMO flow to less than 60 min. We hypothesize that the initiation of Extracorporeal Cardiopulmonary Resuscitation (ECPR) by a Helicopter Emergency Medical Services System (HEMS) will reduce the low flow time and improve outcomes in refractory Out of Hospital Cardiac Arrest (OHCA) patients.
METHODS: The ON-SCENE study will use a non-randomised stepped wedge design to implement ECPR in patients with witnessed OHCA between the ages of 18-50 years old, with an initial presentation of shockable rhythm or pulseless electrical activity with a high suspicion of pulmonary embolism, lasting more than 20, but less than 45 min. Patients will be treated by the ambulance crew and HEMS with prehospital ECPR capabilities and will be compared with treatment by ambulance crew and HEMS without prehospital ECPR capabilities. The primary outcome measure will be survival at hospital discharge. The secondary outcome measure will be good neurological outcome defined as a cerebral performance categories scale score of 1 or 2 at 6 and 12 months.
DISCUSSION: The ON-SCENE study focuses on initiating ECPR at the scene of OHCA using HEMS. The current in-hospital ECPR for OHCA obstacles encompassing low survival rates in refractory arrests, extended low-flow durations during transportation, and the critical time sensitivity of initiating ECPR, which could potentially be addressed through the implementation of the HEMS system. When successful, implementing on-scene ECPR could significantly enhance survival rates and minimize neurological impairment.
TRIAL REGISTRATION: Clinicaltyrials.gov under NCT04620070, registration date 3 November 2020.
参考来源
- Ali S, Moors X, van Schuppen H, et al. A national multi centre pre-hospital ECPR stepped wedge study; design and rationale of the ON-SCENE study. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38632661. doi:10.1186/s13049-024-01198-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。